Page last updated: 2024-08-25

bindarit and Coronary Restenosis

bindarit has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basavarajaiah, S; Calabresi, M; Colombo, A; Guglielmotti, A; Lettieri, C; Limbruno, U; Picchi, A; Pierucci, D; Prati, F; Sciahbasi, A; Valgimigli, M1

Trials

1 trial(s) available for bindarit and Coronary Restenosis

ArticleYear
A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016, Dec-10, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Indazoles; Male; Middle Aged; Percutaneous Coronary Intervention; Propionates; Treatment Outcome; Young Adult

2016